• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

III型巴特综合征患者的分子分析:利用半定量PCR检测大片段杂合缺失

Molecular analysis of patients with type III Bartter syndrome: picking up large heterozygous deletions with semiquantitative PCR.

作者信息

Nozu Kandai, Fu Xue Jun, Nakanishi Koichi, Yoshikawa Norishige, Kaito Hiroshi, Kanda Kyoko, Krol Rafal Przybyslaw, Miyashita Ritsuko, Kamitsuji Hidekazu, Kanda Shoichiro, Hayashi Yoshiki, Satomura Kenichi, Shimizu Nobuhiko, Iijima Kazumoto, Matsuo Masafumi

机构信息

Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Hyogo, 6500017, Japan.

出版信息

Pediatr Res. 2007 Sep;62(3):364-9. doi: 10.1203/PDR.0b013e318123fb90.

DOI:10.1203/PDR.0b013e318123fb90
PMID:17622951
Abstract

Type III Bartter syndrome (BS) (OMIM607364) is caused by mutations in the basolateral chloride channel CIC-Kb gene (CLCNKB). The CLCNKB gene is sometimes reported as having a large deletion mutation, but all cases reported previously were large homozygous deletions and a large heterozygous deletion is impossible to detect by direct sequencing. This report concerns a genetic analysis of five Japanese patients with type III BS. To identify the mutations, we used polymerase chain reaction (PCR) and direct sequencing. To detect large heterozygous deletion mutations of the CLCNKB gene, we conducted semiquantitative PCR amplification using capillary electrophoresis. The result was that four mutations were identified, comprising one novel 2-bp deletion mutation, an entire heterozygous deletion, and a heterozygous deletion mutation of exons 1 and 2. The nonsense mutation W610X was detected in all patients, and this mutation is likely to constitute a founder effect in Japan. Capillary electrophoresis is a new method and extremely useful for detecting large heterozygous deletions, and should be used to examine type III BS cases in whom only a heterozygous mutation has been detected by direct sequencing. This is the first report to identify large heterozygous deletion mutations in the CLCNKB gene in patients with type III BS.

摘要

III型巴特综合征(BS)(OMIM607364)由基底外侧氯通道CIC-Kb基因(CLCNKB)突变引起。CLCNKB基因有时报道存在大片段缺失突变,但此前报道的所有病例均为大片段纯合缺失,大片段杂合缺失无法通过直接测序检测到。本报告涉及5例日本III型BS患者的基因分析。为鉴定突变,我们采用聚合酶链反应(PCR)和直接测序。为检测CLCNKB基因的大片段杂合缺失突变,我们使用毛细管电泳进行半定量PCR扩增。结果鉴定出4种突变,包括1种新的2碱基缺失突变、1种完全杂合缺失以及外显子1和2的杂合缺失突变。在所有患者中均检测到无义突变W610X,该突变在日本可能构成奠基者效应。毛细管电泳是一种检测大片段杂合缺失的新方法且极为有用,应用于直接测序仅检测到杂合突变的III型BS病例的检查。这是首篇报道在III型BS患者中鉴定出CLCNKB基因大片段杂合缺失突变的文章。

相似文献

1
Molecular analysis of patients with type III Bartter syndrome: picking up large heterozygous deletions with semiquantitative PCR.III型巴特综合征患者的分子分析:利用半定量PCR检测大片段杂合缺失
Pediatr Res. 2007 Sep;62(3):364-9. doi: 10.1203/PDR.0b013e318123fb90.
2
Genetic basis of Bartter syndrome in Korea.韩国巴特综合征的遗传基础。
Nephrol Dial Transplant. 2012 Apr;27(4):1516-21. doi: 10.1093/ndt/gfr475. Epub 2011 Aug 23.
3
Molecular analysis of digenic inheritance in Bartter syndrome with sensorineural deafness.伴有感音神经性耳聋的巴特综合征双基因遗传的分子分析。
J Med Genet. 2008 Mar;45(3):182-6. doi: 10.1136/jmg.2007.052944.
4
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III.氯离子通道基因CLCNKB的突变会导致III型巴特综合征。
Nat Genet. 1997 Oct;17(2):171-8. doi: 10.1038/ng1097-171.
5
Identification and functional analysis of novel mutations of the CLCNKB gene in Chinese patients with classic Bartter syndrome.鉴定和功能分析中国经典型巴特综合征患者 CLCNKB 基因的新型突变。
Clin Genet. 2010 Feb;77(2):155-62. doi: 10.1111/j.1399-0004.2009.01288.x. Epub 2009 Oct 6.
6
Alport syndrome. Molecular genetic aspects.奥尔波特综合征。分子遗传学方面。
Dan Med Bull. 2009 Aug;56(3):105-52.
7
Genetics of type III Bartter syndrome in Spain, proposed diagnostic algorithm.西班牙 III 型巴特综合征的遗传学研究及诊断算法的建立
PLoS One. 2013 Sep 18;8(9):e74673. doi: 10.1371/journal.pone.0074673. eCollection 2013.
8
A New Case Report of a CLCNKB Complex Heterozygous Mutation in Adult-Onset Type III Bartter Syndrome.成人发病型 III 型巴特综合征中一个 CLCNKB 复合杂合突变的新病例报告。
Clin Lab. 2024 Aug 1;70(8). doi: 10.7754/Clin.Lab.2024.240211.
9
A novel mutation associated with Type III Bartter syndrome: A report of five cases.一种与 III 型巴特综合征相关的新型突变:五例报告。
Mol Med Rep. 2019 Jul;20(1):65-72. doi: 10.3892/mmr.2019.10255. Epub 2019 May 16.
10
Molecular analysis of the CLCNKB gene in Japanese patients with classic Bartter syndrome.日本经典型巴特综合征患者CLCNKB基因的分子分析。
Endocr J. 2006 Oct;53(5):647-52. doi: 10.1507/endocrj.k06-034. Epub 2006 Aug 11.

引用本文的文献

1
Long-read sequencing identifies a common transposition haplotype predisposing for CLCNKB deletions.长读测序鉴定出一种常见的易位单体型,导致 CLCNKB 缺失。
Genome Med. 2023 Aug 23;15(1):62. doi: 10.1186/s13073-023-01215-1.
2
Clinical and genetic approach to renal hypomagnesemia.肾脏低镁血症的临床与基因研究方法。
Biomed J. 2022 Feb;45(1):74-87. doi: 10.1016/j.bj.2021.11.002. Epub 2021 Nov 10.
3
Historical and geographical distribution of the founder mutation c.610G>A; p.Ala204Thr in the gene linked to Bartter syndrome type III in Spain.
西班牙与III型巴特综合征相关基因中始祖突变c.610G>A;p.Ala204Thr的历史和地理分布。
Clin Kidney J. 2021 Apr 28;14(8):1990-1993. doi: 10.1093/ckj/sfab083. eCollection 2021 Aug.
4
Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases.下一代测序的靶向广泛基因检测为肾脏病患者的诊断和治疗提供了信息。
Nephrol Dial Transplant. 2021 Jan 25;36(2):295-305. doi: 10.1093/ndt/gfz173.
5
Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases.利用下一代测序数据通过配对分析检测遗传性肾脏疾病中的拷贝数变异。
Clin Exp Nephrol. 2018 Aug;22(4):881-888. doi: 10.1007/s10157-018-1534-x. Epub 2018 Jan 25.
6
Clinical and Genetic Spectrum of Bartter Syndrome Type 3.3型巴特综合征的临床和遗传谱系
J Am Soc Nephrol. 2017 Aug;28(8):2540-2552. doi: 10.1681/ASN.2016101057. Epub 2017 Apr 5.
7
Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome.在一大系列III型巴特综合征患者中,表型与基因型关联不佳。
PLoS One. 2017 Mar 13;12(3):e0173581. doi: 10.1371/journal.pone.0173581. eCollection 2017.
8
Characterization of contiguous gene deletions in COL4A6 and COL4A5 in Alport syndrome-diffuse leiomyomatosis.奥尔波特综合征-弥漫性平滑肌瘤病中COL4A6和COL4A5相邻基因缺失的特征分析
J Hum Genet. 2017 Jul;62(7):733-735. doi: 10.1038/jhg.2017.28. Epub 2017 Mar 9.
9
Mutations in SLC12A3 and CLCNKB and Their Correlation with Clinical Phenotype in Patients with Gitelman and Gitelman-like Syndrome.吉特曼综合征和类吉特曼综合征患者中SLC12A3和CLCNKB的突变及其与临床表型的相关性
J Korean Med Sci. 2016 Jan;31(1):47-54. doi: 10.3346/jkms.2016.31.1.47. Epub 2015 Dec 24.
10
Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations.巴特综合征和吉特林综合征:由不同突变引起的临床表现谱。
World J Methodol. 2015 Jun 26;5(2):55-61. doi: 10.5662/wjm.v5.i2.55.